http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2269069-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac27857c8fed75d8a8b2fdfaccbb1d5f |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-05 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56994 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate | 2009-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_014668fe211f9a003847500e4a0cfa7b |
publicationDate | 2011-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2269069-B1 |
titleOfInvention | Use of synthetic peptide derived from zebra protein for the in vivo diagnosis of the epstein-barr virus (ebv) reactivation |
abstract | The present invention discloses the use of polypeptide derived from ZEBRA protein, or variants or isoforms of the said polypeptide for the i n vitro and ex vivo screening of the EBV virus reactivation in a biological sample of a subject afflicted by a pathology associated with EBV infection. |
priorityDate | 2008-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.